LOG IN

Members and suppliers: Join our online community

Access our full library of resources, register for events and webinars and share audits and other assessments

News

Sort By
This event was published on 29 October
Registration Open
Webinar: AMRの脅威と製薬企業の責任 The Threat of AMR and Pharmaceutical Responsibility

Webinar: AMRの脅威と製薬企業の責任 The Threat of AMR and Pharmaceutical Responsibility

Webinar | 22 Dec 2025 15:00–16:00 Tokyo

この講演の言語は日本語です
This presentation will be delivered in Japanese

テーマ
AMRの脅威と製薬企業の責任:製薬業界をあげた活動とSHIONOGIグループの取り組み

PSCIアカウントに登録/ログイン後、申し込みができます。申し込みは12月17日午後5時までとなります。参加ガイドメールは12月18日に送信されます。

講演者
大橋 興三,コーポレートガバナンス部 総務EHS担当者

SHIONOGIグループにおけるEHS(環境・健康・安全)統括組織での3年間の経験を有し、AMR(薬剤耐性)対策における責任ある製造の推進を担当。AMR Industry AllianceのManufacturing Working Groupメンバーとして、国際的な枠組みにおける製造環境改善にも取り組んでいる。以前は18年間にわたり臨床開発部門にて新薬の開発業務に従事し、抗菌薬の開発にも携わる。

概略
薬剤耐性菌(AMR:Antimicrobial Resistance)は、世界の医療に深刻な影響を及ぼす重要な課題です。本Webinarでは、AMRの基本的な知識をわかりやすく解説し、製薬業界がどのように対応すべきかをご紹介します。
具体的には、AMR Industry Allianceによる抗菌薬製造基準(Antibiotic Manufacturing Standard)や、新たな認証制度を取り上げ、業界全体で進められている取り組みを理解します。
さらに、SHIONOGIグループが推進する具体的な施策についてもご紹介し、持続可能な医療の実現に向けた道筋を考えます。
AMR問題の本質と解決へのアプローチを学ぶ貴重な機会です。ぜひご参加ください。

Topic
The Threat of AMR and Pharmaceutical Responsibility: Industry-Wide Initiatives in the Pharmaceutical Sector and SHIONOGI Group’s Commitment

Presenter
Kozo Ohashi, EHS Management Group Member, Corporate Governance Department, Shionogi

Kozo Ohashi has three years of experience in the Environmental, Health, and Safety (EHS) management division of the SHIONOGI Group, where he led initiatives for responsible manufacturing in the context of antimicrobial resistance (AMR). He is also a member of the Manufacturing Working Group of the AMR Industry Alliance, contributing to global efforts to improve manufacturing practices in the fight against AMR. Prior to this role, he spent 18 years in clinical development, contributing to the research and development of new drugs, including antibiotics.

Introduction
Antimicrobial Resistance (AMR) is a critical global challenge that poses serious threats to healthcare systems worldwide. This webinar will provide a clear overview of the fundamentals of AMR and outline how the pharmaceutical industry should respond to this pressing issue.
It will introduce the Antibiotic Manufacturing Standard developed by the AMR Industry Alliance and highlight emerging certification schemes designed to ensure responsible practices across the industry. In addition, key initiatives led by the SHIONOGI Group will be presented, illustrating the path toward sustainable healthcare.
This session offers a valuable opportunity to deepen your understanding of AMR and explore practical approaches to addressing this global concern. We look forward to your participation.

Type
Webinar
Date
22 Dec 2025 15:00–16:00 Tokyo
Language
Japanese
Add To Calendar

If you have a PSCI account, please log in first so your information will be filled automatically.

All fields are required except where specified. Please enter all information in English.

Full Members

  • Abbott
  • Acino International AG
  • AstraZeneca
  • Aurobindo
  • BASF Pharma
  • Bayer
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Centrient Pharmaceuticals
  • Coloplast
  • Elanco Animal Health
  • Grunenthal GmbH
  • GSK
  • Haleon
  • Johnson & Johnson
  • Kenvue
  • Lilly
  • Mallinckrodt
  • Merck & Co.
  • Novartis
  • Novo Nordisk
  • Orion
  • Pfizer
  • Piramal
  • Roche
  • Sandoz
  • Sanofi
  • Sartorius
  • Takeda
  • Teva
  • UCB
  • Viatris
  • West Pharmaceutical Services Inc.
  • Zoetis

Associate Members

  • AbbVie
  • Alkem Laboratories
  • Almirall
  • Amgen
  • Amgros
  • Aragen Life Sciences Limited
  • Aspen Pharmacare
  • Bavarian Nordic
  • Baxter
  • Becton Dickinson
  • Biogen
  • Charles River Laboratories
  • Chiesi
  • Chugai Pharmaceutical
  • Cipla
  • CSL Limited
  • Eisai Co., Limited
  • Esteve
  • Evolan Pharma AB
  • Fabbrica Italiana Sintetici S.p.a.
  • Fagron
  • Fosun Pharma
  • Fresenius Kabi
  • Gilead
  • Hameln Pharma
  • Immedica Pharma
  • IOI Oleo
  • Karo Healthcare
  • Kyowa Kirin
  • LEO Pharma
  • Mallax Pharmaceutical
  • Merck KGaA
  • Moderna
  • Nordic Group B.V.
  • Ono Pharmaceuticals
  • Organon
  • Orifarm
  • Perrigo Company
  • Sai Life Sciences
  • Shionogi
  • SK Biopharmaceuticals
  • Sobi
  • STADA
  • Sterling Pharma Solutions
  • ten23 health
  • Tiefenbacher Group
  • Vertex
  • Vetoquinol
  • Xellia Pharmaceuticals
  • Zentiva

We will not pass on these details to third parties and will use them only to contact you about this event, or other PSCI events we think you may be interested in.

Please contact us if you find you can no longer attend.

I understand that these details will be used by the PSCI to identify me and to send me communications relating to this, and future, PSCI events.

Leave this field blank if you are a human.
Registration Closes: 17 Dec 2025
If you have a user account, please log in before registering.
This bulletin was published on 24 October
PSCI Member Sandra Matamoros to speak on partnerships to tackle Scope 3 in the pharma value chain

PSCI Member Sandra Matamoros to speak on partnerships to tackle Scope 3 in the pharma value chain

Don’t miss this opportunity to hear from industry leaders shaping the future of resilient and sustainable supply chains

Tackling Scope 3 emissions – those indirect emissions that occur in a company’s value chain – is one of the greatest sustainability challenges facing the pharmaceutical sector. No single company can achieve Net-Zero targets alone. This panel explores how cross-industry collaboration, data transparency, and the right technology partners are helping pharma make real progress.

  • How companies are overcoming barriers to sharing Scope 3 emissions data with suppliers and partners.
  • Strategies for getting suppliers aligned on decarbonisation goals and reporting standards.
  • A spotlight on tools like Manufacture 2030 and how they are enabling scalable, verified emissions tracking and reduction efforts.

Speakers

  • Sushree Mishra, Head - Global Corporate Strategy, Corporate Communications & Inlicensing, JB Pharma
  • Peylina Chu, Chair, Steering Committee, CPHI Sustainability Collective
  • Ines Windisch, Head of Corporate Affairs & Sustainability, Zentiva
  • Sandra Matamoros, Global Program Lead Responsible Sourcing, Grunenthal Pharma & CO KG
  • Darryl Ratty, Executive Director, Global ESG, SK pharmteco

Panel Details
Panel: Collective Action, Real Results: The Power of Partnership on Scope 3 Emissions
Date: Tuesday, October 28, 2025
Time: 11:35 AM to 12:20 PM (CET)
Location: Hall 4 - 4.0G36, CPHI Frankfurt

Find out more information here.

This event was published on 23 October
Registration Open
PSCI Webinar: REACH an Introduction

PSCI Webinar: REACH an Introduction

Webinar | 9 Dec 2025 13:00–14:00 London

What to Expect: REACH (EC Regulation No. 1907/2006) REACH is a regulation of the European Union aimed at improving the protection of human health and the environment from exposure to chemicals. It settles a set of procedures to ensure a proper assessment and management of risks associated with the use of substances.

Via the registration process, companies need to demonstrate to authorities the safe use of the substances they manufacture; the regulation places the burden of proof on companies.

By attending this webinar, you will get an overview of basic principles of REACH and procedures to follow to market chemicals across EU.

  • Speaker: Mr. Simone Canepa – REACH manager at Olon S.p.A. Bio: Chemist by education, I have been dealing with REACH regulation since 2007; at first, for a consultancy firm, assessing the impact of the REACH provisions on companies’ activities, helping them to prepare themselves to its implementation; later, supporting companies to meet the “new” requirements. Joined in Olon since 2015, I’m in charge for all REACH related activities of the Group.

We look forward to having you attend the event!

Type
Webinar
Date
9 Dec 2025 13:00–14:00 London
Language
English
  • Chemical Registrations
This bulletin was published on 21 October
PSCI Chair Robert Williams to Speak on Challenges to the Sustained Availability of Excipients

PSCI Chair Robert Williams to Speak on Challenges to the Sustained Availability of Excipients

Don’t miss this opportunity to hear from industry leaders shaping the future of resilient and sustainable supply chains

Ensuring the sustained availability of excipients is becoming increasingly complex due to evolving regulations, supply chain vulnerabilities, and the pressing demand for sustainable solutions. This panel will explore critical challenges and opportunities for securing the long-term availability of excipients across industries.

Key discussion points include:

  • How shifting legislation, particularly in other sectors, is limiting excipient options, such as restrictions on recycled plastics for food-grade applications.
  • The growing need for novel excipients to meet evolving industry requirements while maintaining safety and efficacy.
  • Best practices for fortifying supply chains against disruptions and ensuring consistent availability.
  • Exploring how green practices can be effectively incorporated into excipient production and supply, balancing innovation with environmental responsibility

Speakers

  • Felicity Thomas, Associate Director of Editorial and Content, The Pharma Navigator
  • Iain Moore, Senior Advisor Operations, EXCiPACT asbl
  • Nigel Langley, Global Technical Director Life Sciences, gChem
  • Robert Williams, Chair, PSCI
  • Bram Baert, Senior Director Regulatory Affairs, Lonza Capsules & Health Ingredients

Panel Details
Challenges to the Sustained Availability of Excipients
Date: Wednesday, October 29, 2025
Time: 11:35 AM – 12:20 PM (CET)
Location: Hall 12.1 - 12.1C68, CPHI Frankfurt

Find out more information here.

This event was published on 14 October
Registration Open
PSCI Webinar: Road Safety - India

PSCI Webinar: Road Safety - India

Webinar | 6 Nov 2025 15:00–16:30 Kolkata

The commercial and sales teams in the pharmaceutical industry spend a significant amount of time traveling to meet healthcare providers, distributors, and customers across diverse geographies. Road safety is the number one risk in India and road incidents directly impact personal safety, business continuity, and customer engagement.

This session will cover key aspects of road safety including safe driving practices and behaviours, managing fatigue and stress on the road, and the importance of avoiding distractions while driving. Demonstrating leadership in road safety strengthens employee engagement, corporate reputation, supports ESG commitments, and contributes to India’s National Road Safety Mission. By participating, you can help your organizations drive collective action towards a safer, more responsible, and resilient pharmaceutical ecosystem.

Speakers:

Mahesh Chandak

Head of SSHE - South Asia and Global Road Safety Lead, Bayer

Mahesh is a Sustainability, Safety, Health, Environment (SSHE) Leader with 30 years of diverse consulting and industry experience. He heads the SSHE function at Bayer in South Asia and leads the Bayer Global Road Safety Program to promote road safety awareness, ensuring compliance, leveraging tools and digitalization to strengthen road safety culture in the organisation.  He also advocates for sustainability and road safety in industry forums, actively sharing his perspectives. Recognized as Sustainability thought leader in various prestigious industry forums, he is Co-Chair of BCCI sustainability committee and responsible for health & safety activities and part of FICCI Road Safety committee. He is also a nominated jury member for several esteemed SSHE industry awards by CII & BCCI.

Rajani Chavan

SSHE Enablement Lead, South Asia and India Road Safety lead, Bayer

Rajani is a SSHE professional with more than 24 years of work experience in HSE consulting and industry sectors.  She has extensive experience in conducting sustainable supply chain assessments and is well-versed with HSE and Social Management Systems.

In current role, Rajani is HSE business partner for the Bayer Asia seeds product supply business and has enhanced Sustainability and HSE program maturity across own sites, tollers and growers. She represents APAC region in the Bayer Global Human rights community and provides regulatory governance and technical HSE expert support to Bayer India sites. She also leads the India Road Safety program, which has significantly improved in maturity and performance over the past few years and awarded the CII South Region EHS Excellence Award.

Type
Webinar
Date
6 Nov 2025 15:00–16:30 Kolkata
Language
English
This bulletin was published on 8 October
PSCI Past Chair Deirdre O’Reilly to speak on supply chain excellence at CPHI Frankfurt

PSCI Past Chair Deirdre O’Reilly to speak on supply chain excellence at CPHI Frankfurt

Don’t miss this opportunity to hear from industry leaders shaping the future of resilient and sustainable supply chains

In the pursuit of business excellence, organisations must go beyond efficiency and cost to build operations that are sustainable, resilient, and future-ready. At the heart of this transformation lies the supply chain.

Hear from PSCI Past Chair Deirdre O’Reilly at CPHI Frankfurt 2025 for a dynamic panel discussion exploring how integrating sustainability into supply chain strategies not only reduces risk, but also drives operational excellence, meets investor expectations, and strengthens brand trust.

Participants will gain actionable insights into five essential elements of supply chain excellence:

  • Proactively Managing Supply Chain Risk
  • Identifying and Addressing Vulnerabilities
  • Aligning with Investor and Stakeholder Expectations
  • Embedding Resilience as a Core Competency
  • Driving Continuous Improvement and Strategic Action

Speakers

  • Deirdre O'Reilly, Past Chair, PSCI
  • Ximena Stawsky, Healthcare Supply Chain Head Europe, Merck KGaA Germany
  • Gabriele Harttung, Global Head CoE Human Rights, Boehringer Ingelheim
  • Guy Stone, Head of Business Continuity Management Roche Diagnostics, Roche

Panel Details
Supply Chains Under Pressure: Building for Strength, Not Just Speed
Date: Wednesday, October 29, 2025
Time: 11:20 AM – 12:20 PM (CET)
Location: Hall 4 - 4.0G36, CPHI Frankfurt

Find out more information here.

This bulletin was published on 26 September
PSCI India Conference 2025 celebrates 10 years of impact

PSCI India Conference 2025 celebrates 10 years of impact

The 2025 PSCI India Supplier Conference, held from September 24-26 in Chandigarh, was a tremendous success, drawing over 750 participants across three days, This high turnout, thanks to the active involvement of PSCI members, reflected the strong interest in responsible supply chain practices across the sub-continent.

Some significant highlights included:

  • Celebrating the 10th anniversary of the Conference
  • Welcoming over 750 participants across three days
  • Donating 350 saplings on behalf of all registered participants to a local organization
  • Inviting 10 unique exhibition stalls featuring EHS and sustainability-linked solutions and organizations across the range of this year’s conference topics

The 2025 India Conference also included some notable innovations and firsts, such as:

  • The Wall of Impact: 35 excellent stories were shared from suppliers on their engagement with PSCI and the impact it's created through new initiatives and projects
  • A workshop was conducted with all participants for identifying improvement opportunities across the value chain with excellent engagement and great feedback
  • A diverse leadership panel discussion was a highlight of the conference
  • 8 technical sessions were delivered by subject matter experts across a range of topics that were all very well received and saw high engagement

Many thanks are owed to the hard work and dedication of the India Sub-team who delivered the event itself, including Aditya Shirodkar, Rohit Virmani, and Ranjana Ganguly, and the rest of the India team who devoted their time and efforts.

The success of this conference demonstrates the PSCI’s commitment to creating positive impact and promoting accountability, speaking as one voice for the industry.

This bulletin was published on 26 September
The PSCI at CPHI Frankfurt 2025

The PSCI at CPHI Frankfurt 2025

PSCI to exhibit as an Official Sustainability Partner of CPHI Frankfurt from 28-30 October in Frankfurt, Germany

The PSCI is delighted to be returning to CPHI Frankfurt to raise awareness about building responsible supply chains at the world's largest pharma industry show.

Meet with us on-site
Are you or your Marketing & BD colleagues attending the event? Contact the Secretariat to schedule a meeting.

Join us at the Sustainability Theatre
Hear from Deidre O'Reilly, Past Chair, on Supply Chains Under Pressure: Building for Strength, Not Just Speed.

In the pursuit of business excellence, organisations must go beyond efficiency and cost to build operations that are sustainable, resilient, and future-ready. Supply chains are at the heart of this transformation. Join this panel to explore how integrating sustainability into supply chain strategies not only reduces risk, but also drives operational excellence, meets investor expectations, and strengthens brand trust.

Showcase your PSCI engagement on your stand
We encourage you to display the PSCI logo or Supplier Partner badge on your own exhibition stand and marketing materials. This not only demonstrates your commitment to responsible practices, but also shows your relationship to the industry's leading association for delivering responsible value chains. Contact the Secretariat for the assets and share them with your Marketing team.

Access your discounted ticket
Use our special code for a discount on your ticket to CPHI - SPTO191

This event was published on 26 September
CPHI Frankfurt

CPHI Frankfurt

External | 28–30 Oct 2025

The PSCI is delighted to be an Official Sustainability Partner for CPHI Frankfurt, the biggest international pharma industry event, for the fourth year in a row.

We'll be exhibiting throughout the conference in Frankfurt from 28-30 October 2025.

The PSCI stand H25 will be located in Hall 4.0, where we will be showcasing the impact that the PSCI has through the pharmaceutical supply chain.

Meet with us on-site
Please contact the Secretariat if you are planning to attend and would like to arrange a meeting.

Discount code
Use our special code for a discount on your ticket to CPHI - SPTO191

Type
External
Date
28–30 Oct 2025
Language
English
This event is in the past
This resource was published on 16 September

The PSCI Principles

Organisational Information

The 2023 revision of the PSCI Principles (PSCI Principles v3.0) was approved by the membership on Tuesday 23rd May 2023, at the Spring Meeting in Paris (France), and became effective immediately.

The PSCI Principles for Responsible Supply Chain Management are foundational, setting members' expectations of suppliers, and form the base for all PSCI's tools and materials.

These Principles set the standard for governance and management systems, ethics, human rights, health and safety, and environmental business practices.

The Principles are adopted by all PSCI members and may be voluntarily supported by any business in the pharmaceutical and healthcare industry.

  • Ethics
  • Human Rights & Labor
  • Health & Safety
  • Environment
  • Management Systems